Literature DB >> 15195757

What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.

Tatsuya Higashi1, Tsuneo Saga, Takayoshi Ishimori, Marcelo Mamede, Koichi Ishizu, Toru Fujita, Takahiro Mukai, Seiji Sato, Hironori Kato, Yoshio Yamaoka, Keiichi Matsumoto, Michio Senda, Junji Konishi.   

Abstract

PURPOSE: To evaluate the appropriate post-injection timing for hand-held-gamma-ray-detecting probe (GDP) scanning for the intraoperative detection of malignancy after preoperative F-18 FDG (FDG) injection.
METHODS: Patient study with superficially located cancer was performed on three patients before operation by dual-phase whole-body PET at 2 and 6-7 hr post-injection of FDG (370 MBq), and by probe scanning from the skin at several points at 1, 3, 5, and 7 hr after FDG injection. TNRa (tumor-adjacent-normal ratio) and TNRc (tumor-contralateral-normal ratio) were calculated. Phantom study was also performed to determine basic GDP function.
RESULTS: The patient study revealed that tumors showed constant TNRa (0.9-1.3) and TNRc (1.1-3.0) by GDP count rate, and that there was no tendency of an increase in TNRa with time. The standard deviations of GDP count rate were lower at 1-3 hr post-injection compared with those of delayed scans. While delayed PET showed an increase or no change in the tumor FDG uptake, the decrease of normal tissue FDG uptake was not adequate to create higher TNRs. The phantom study revealed that LN model showed TNRa of 1.7 or greater by GDP count rate (cps) when background contained no FDG, but that they showed TNRa of 1.3 or less when the background contained 4% of the LN FDG activity per ml.
CONCLUSION: The present study suggests that higher FDG count rate of tumors at 1-3 hr postinjection would be more suitable for the gamma-probe detection compared with lower count rate at 6-7 hr delayed scans with wide standard deviations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195757     DOI: 10.1007/bf02985100

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  8 in total

1.  Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes.

Authors:  Segundo J González; Joyce Wong; Lorena González; Peter Brader; Maureen Zakowski; Mithat Gönen; Yuman Fong; Vivian E Strong
Journal:  Surg Endosc       Date:  2011-04-22       Impact factor: 4.584

2.  PET probes and oncological surgery: a productive new marriage for nuclear medicine?

Authors:  Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

3.  An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue.

Authors:  Segundo Jaime González; Lorena González; Joyce Wong; Peter Brader; Maureen Zakowski; Mithat Gönen; Farhad Daghighian; Yuman Fong; Vivian E Strong
Journal:  J Gastrointest Surg       Date:  2010-11-25       Impact factor: 3.452

4.  Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Andrew Z Chow; Jay R Gaglani; Eamonn E Bahnson; Cathy M Mojzisik; Maureen P Kuhrt; Charles L Hitchcock; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2011-11-23       Impact factor: 2.754

5.  Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Chadwick L Wright; Edward W Martin
Journal:  BMC Cancer       Date:  2015-05-08       Impact factor: 4.430

6.  Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer.

Authors:  Nathan C Hall; Stephen P Povoski; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2007-12-21       Impact factor: 2.754

7.  18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.

Authors:  Stephen P Povoski; Douglas A Murrey; Sabrina M Smith; Edward W Martin; Nathan C Hall
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

8.  Comparison of two threshold detection criteria methodologies for determination of probe positivity for intraoperative in situ identification of presumed abnormal 18F-FDG-avid tissue sites during radioguided oncologic surgery.

Authors:  Gregg J Chapman; Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Robert Lee; Edward W Martin
Journal:  BMC Cancer       Date:  2014-09-13       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.